Three-year 10% note, sold to Pabeti, also includes 3 million warrants
By Devika Patel
Knoxville, Tenn., June 7 - Accentia Biopharmaceuticals, Inc. sold a $1.5 million three-year convertible secured promissory note to Pabeti, Inc. on June 1, according to an 8-K filed Thursday with the Securities and Exchange Commission.
The 10% note matures on June 1, 2015, and is initially convertible into common shares at $0.25 per share, a 7.41% discount to the May 31 closing share price of $0.27.
Pabeti also will receive warrants for 3 million common shares, which are exercisable at $0.28 until June 1, 2020. The warrant strike price is a 3.7% premium to the May 31 closing share price.
Accentia is a biopharmaceutical company based in Tampa, Fla.
| Issuer: | Accentia Biopharmaceuticals, Inc.
|
| Issue: | Convertible secured promissory note
|
| Amount: | $1.5 million
|
| Maturity: | June 1, 2015
|
| Coupon: | 10%
|
| Conversion price: | $0.25
|
| Warrants: | For 3 million shares
|
| Warrant expiration: | June 1, 2020
|
| Warrant strike price: | $0.28
|
| Investor: | Pabeti, Inc.
|
| Settlement date: | June 1
|
| Stock symbol: | Nasdaq: ABPI
|
| Stock price: | $0.27 at close May 31
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
